Attached files
| file | filename |
|---|---|
| EX-99.1 - EXHIBIT 99.1 - NATUS MEDICAL INC | a50665583ex99_1.htm |
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Form
8-K
Current Report
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
Date of Report
(Date of earliest event reported): July
8, 2013
|
Natus Medical Incorporated |
|
(Exact name of registrant as specified in its charter) |
|
000-33001 |
|
(Commission File Number) |
|
Delaware |
|
77-0154833 |
||
|
(State or other jurisdiction of incorporation) |
|
(I.R.S Employer Identification No.) |
|
1501 Industrial Road |
|
(Address of principal executive offices, with zip code) |
|
650-802-0400 |
|
(Registrant's telephone number, including area code) |
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
⃞ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
⃞ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
⃞ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
⃞ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
ITEM 2.02. Results of Operations and Financial Condition.
Attached hereto as Exhibit 99.1 and incorporated by reference herein is information regarding the Company’s press release of July 8, 2013 announcing preliminary second quarter 2013 revenue results.
ITEM 9.01. Financial Statements and Exhibits.
(d) Exhibits.
|
Exhibit No. |
Description |
|
| 99.1 | Attached hereto as Exhibit 99.1 and incorporated by reference herein is information regarding the Company’s press release of July 8, 2013 announcing preliminary second quarter 2013 revenue results. |
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of
1934, the registrant has duly caused this report to be signed on its
behalf by the undersigned hereunto duly authorized.
|
NATUS MEDICAL INCORPORATED |
|||
|
(Registrant) |
|||
|
|
|
By: |
/s/ Jonathan A. Kennedy |
|
|
Jonathan A. Kennedy |
||
|
|
Sr. Vice President Finance and Chief Financial Officer |
||
|
Dated: |
July 8, 2013 |
||
Exhibit Index
|
Exhibit |
Description |
|
| 99.1 |
Attached hereto as Exhibit 99.1 and incorporated by reference herein is information regarding the Company’s press release of July 8, 2013 announcing preliminary second quarter 2013 revenue results. |